Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement

Annals of Internal Medicine

Volumn 162, Issue 9, 2015, Pages 641-650

  LeFevre, Michael L ^a   Siu, Albert L ^b   Bibbins Domingo, Kirsten ^c   Baumann, Linda Ciofu ^d   Karina, W Davidson ^e   Ebell, Mark ^f   García, Francisco A R ^g   Gillman, Matthew ^h   Herzstein, Jessica ⁱ   Kemper, Alex R ^j   Krist, Alexander H ^k   Kurth, Ann E ^l   Owens, Douglas K ^m   Phillips, William R ⁿ   Phipps, Maureen G ^o   Pignone, Michael P ^p  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f UNIVERSITY OF GEORGIA   (United States)

^g Pima County Health Department   (United States)

^h HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

ⁱ Duke University ^*  (United States)

^j DUKE UNIVERSITY   (United States)

^k VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^l NEW YORK UNIVERSITY   (United States)

^m STANFORD UNIVERSITY   (United States)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

^o BROWN UNIVERSITY   (United States)

^p UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE SODIUM; THYROTROPIN; THYROXINE; THYROID HORMONE;

ABLATION THERAPY; BONE DENSITY; CLINICAL PRACTICE; CONSTIPATION; CROSS-SECTIONAL STUDY; DECISION MAKING; FALSE POSITIVE RESULT; HAIR LOSS; HEART PALPITATION; HEAT INTOLERANCE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; PHYSICAL DISEASE BY BODY FUNCTION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID GLAND; THYROTROPIN BLOOD LEVEL; WEIGHT GAIN; ADULT; ASYMPTOMATIC DISEASE; BLOOD; EARLY DIAGNOSIS; FEMALE; MALE; MASS SCREENING; MEDICAL RESEARCH; PRACTICE GUIDELINE; THYROID DISEASES; THYROID FUNCTION TEST; UNITED STATES;

ADULT; ASYMPTOMATIC DISEASES; BIOMEDICAL RESEARCH; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MASS SCREENING; RISK ASSESSMENT; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID HORMONES; UNITED STATES;

EID: 84928889678     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-0483     Document Type: Review

References (45)

1. Rugge JB, Bougatsos C, Chou R. Screening for and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force. Evidence synthesis no. 118. AHRQ publication no. 15-05217-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
2. Rugge JB, Bougatsos C, Chou R. Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162:35-45. [PMID: 25347444] doi:10.7326/M14-1456
3. Rugge B, Balshem H, Sehgal R, Relevo R, Gorman P, Helfand M. Screening and treatment of subclinical hypothyroidism or hyperthyroidism. Comparative effectiveness review no. 24. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
4. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-99. [PMID: 11836274]
5. Boucai L, Hollowell JG, Surks MI. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid. 2011;21:5-11. [PMID: 21058882] doi:10.1089/thy.2010.0092
6. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al; Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13:3-126. [PMID: 12625976]
7. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90: 5483-8. [PMID: 16148345]
8. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-38. [PMID: 14722150]
9. Shrier DK, Burman KD. Subclinical hyperthyroidism: controversies in management. Am Fam Physician. 2002;65:431-8. [PMID: 11858626]
10. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292:2591-9. [PMID: 15572717]
11. Díez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89:4890-7. [PMID: 15472181]
12. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab. 2005;90:581-5. [PMID: 15643019]
13. Razvi S, Weaver JU, Butler TJ, Pearce SH. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 2012;172:811-7. [PMID: 22529180] doi:10.1001/archinternmed.2012.1159
14. Rosario PW. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/L: a prospective study. Clin Endocrinol (Oxf). 2010;72:685-8. [PMID: 20447066] doi: 10.1111/j.1365-2265.2009.03696.x
15. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22:1200-35. [PMID: 22954017] doi:10.1089/thy.2012.0205
16. Meyerovitch J, Rotman-Pikielny P, Sherf M, Battat E, Levy Y, Surks MI. Serum thyrotropin measurements in the community: fiveyear follow-up in a large network of primary care physicians. Arch Intern Med. 2007;167:1533-8. [PMID: 17646608]
17. Taylor PN, Iqbal A, Minassian C, Sayers A, Draman MS, Greenwood R, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2014;174:32-9. [PMID: 24100714] doi:10.1001/jamainternmed.2013.11312
18. IMS Institute for Healthcare Informatics. The Use of Medicines in the United States: Review of 2010. Parsippany, NJ: IMS Institute for Healthcare Informatics; 2011. Accessed at www.imshealth.com /deployedfiles/imshealth/Global/Content/IMS%20Institute/Static% 20File/IHII-UseOfMed-report.pdf on 12 February 2015.
19. Brooks M. Top 100 selling drugs of 2013. Medscape Medical News. 30 January 2014.
20. Fatourechi V, Lankarani M, Schryver PG, Vanness DJ, Long KH, Klee GG. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1- 10.0 mIU/L). Mayo Clin Proc. 2003;78:554-60. [PMID: 12744541]
21. Somwaru LL, Arnold AM, Cappola AR. Predictors of thyroid hormone initiation in older adults: results from the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2011;66:809-14. [PMID: 21628677] doi:10.1093/gerona/glr063
22. Wirth CD, Blum MR, da Costa BR, Baumgartner C, Collet TH, Medici M, et al. Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis. Ann Intern Med. 2014; 161:189-99. [PMID: 25089863] doi:10.7326/M14-0125
23. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol. 2008;125:41-8. [PMID: 17434631]
24. Völzke H, Schwahn C, Wallaschofski H, Dörr M. Review: the association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J Clin Endocrinol Metab. 2007;92: 2421-9. [PMID: 17473067]
25. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148: 832-45. [PMID: 18490668] doi:10.7326/0003-4819-148-11- 200806030-00225
26. Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008;93:2998-3007. [PMID: 18505765] doi:10.1210 /jc.2008-0167
27. Razvi S, Weaver JU, Vanderpump MP, Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab. 2010;95:1734-40. [PMID: 20150579] doi:10.1210/jc.2009-1749
28. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid. 1996;6:155-60. [PMID: 8837320]
29. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005;165:2460-6. [PMID: 16314541]
30. Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP, et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health Study. J Am Coll Cardiol. 2008;52:1152-9. [PMID: 18804743] doi:10.1016/j.jacc.2008.07.009
31. Helfand M. Screening for thyroid disease. Systematic evidence review no. 23. Rockville, MD: Agency for Healthcare Research and Quality; 2004.
32. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76-131. [PMID: 17991805]
33. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92:4575-82. [PMID: 17911171]
34. Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab. 2009;94:1251-4. [PMID: 19158193] doi:10.1210 /jc.2008-2325
35. Simonsick EM, Newman AB, Ferrucci L, Satterfield S, Harris TB, Rodondi N, et al; Health ABC Study. Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med. 2009;169: 2011-7. [PMID: 19933964] doi:10.1001/archinternmed.2009.392
36. Caron PJ, Nieman LK, Rose SR, Nisula BC. Deficient nocturnal surge of thyrotropin in central hypothyroidism. J Clin Endocrinol Metab. 1986;62:960-4. [PMID: 3958131]
37. Karmisholt J, Andersen S, Laurberg P. Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism. Thyroid. 2008;18:303-8. [PMID: 18303960] doi:10.1089/thy.2007.0241
38. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med. 1984;101:18-24. [PMID: 6428290] doi:10.7326/0003-4819-101-1-18
39. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab. 2006;91:145-53. [PMID: 16263815]
40. Parle J, Roberts L, Wilson S, Pattison H, Roalfe A, Haque MS, et al. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid Study. J Clin Endocrinol Metab. 2010;95:3623-32. [PMID: 20501682] doi: 10.1210/jc.2009-2571
41. Safi S, Hassikou H, Hadri L, Sbihi A, Kadiri A. [Evaluation of bone mineral density in hyperthyroid patients before and after medical therapy]. Ann Endocrinol (Paris). 2006;67:27-31. [PMID: 16596054]
42. Jørgensen P, Langhammer A, Krokstad S, Forsmo S. Is there an association between disease ignorance and self-rated health? The HUNT Study, a cross-sectional survey. BMJ Open. 2014;4:e004962. [PMID: 24871539] doi:10.1136/bmjopen-2014-004962
43. Overt. Oxford Dictionaries. Oxford Univ Pr. Accessed at www.oxforddictionaries.com/us/definition/american-english/overt on 12 February 2015.
44. Beastall GH, Beckett GJ, Franklyn J, Fraser WD, Hickey J, John R, et al. UK Guidelines for the Use of Thyroid Function Tests. London: Association for Clinical Biochemistry, British Thyroid Association, and British Thyroid Foundation; 2006. Accessed at www.british-thyroid -association.org/info-for-patients/Docs/TFT-guideline-final-version -July-2006.pdf on 12 February 2015.
45. American Academy of Family Physicians. Clinical Preventive Service Recommendation: Thyroid. Leawood, KS: American Academy of Family Physicians; 2015. Accessed at www.aafp.org/patient-care /clinical-recommendations/all/thyroid.html on 12 February 2015.